-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The reporter learned on the 27th that the State Drug Administration approved the application for
registration of innovative products of "proton therapy system" produced by Shanghai enterprises.
In the future, the domestic proton therapy system will be officially put into use
in the Cancer Proton Center of Ruijin Hospital (hereinafter referred to as Ruijin Hospital) affiliated to Shanghai Jiao Tong University School of Medicine.
registration of innovative products of "proton therapy system" produced by Shanghai enterprises.
In the future, the domestic proton therapy system will be officially put into use
in the Cancer Proton Center of Ruijin Hospital (hereinafter referred to as Ruijin Hospital) affiliated to Shanghai Jiao Tong University School of Medicine.
The approved proton therapy system is used to treat solid malignancies and certain benign diseases
throughout the body.
Ruijin Hospital undertakes clinical trials as a clinical trial and carries out clinical trials of fixed beams and 180-degree rotating beam treatment rooms of proton therapy systems from the end of 2021
.
During the six-month clinical trial, the team of Ruijin Hospital verified the accuracy and stability of the proton ray range, determined the clinical application scenarios of the equipment according to the condition characteristics of different subjects, explored and established the proton therapy technology and clinical standardized operation specifications in line with the Chinese group, and formed a systematic, standardized and standardized program
for the application of the proton therapy system to tumor treatment.
throughout the body.
Ruijin Hospital undertakes clinical trials as a clinical trial and carries out clinical trials of fixed beams and 180-degree rotating beam treatment rooms of proton therapy systems from the end of 2021
.
During the six-month clinical trial, the team of Ruijin Hospital verified the accuracy and stability of the proton ray range, determined the clinical application scenarios of the equipment according to the condition characteristics of different subjects, explored and established the proton therapy technology and clinical standardized operation specifications in line with the Chinese group, and formed a systematic, standardized and standardized program
for the application of the proton therapy system to tumor treatment.
The clinical trial results proved that after the subjects were treated by proton beam irradiation, the tumor symptoms, signs and landmark tumor indicators were significantly improved, and the tumor control rate reached 100%, of which nearly half of the subjects' tumor lesions completely disappeared, and 10% of the subjects' tumor foci were significantly reduced; At the same time, the precise "blasting" of the proton beam effectively controls the dose and volume of irradiation on normal tissues, reduces the side effects of radiation therapy on normal tissues and the impact of treatment on the quality of life of
patients.
It is reported that in the next step, Ruijin Hospital will enter the stage
of formal clinical treatment of cancer patients.
patients.
It is reported that in the next step, Ruijin Hospital will enter the stage
of formal clinical treatment of cancer patients.
In February 2011, the Shanghai Municipal Government clearly regarded the "Development of the First Domestic Proton Therapy Device" and the "Ruijin Hospital Tumor Proton Center" project as a strategic and high-tech cooperation project between the Ministry of Science and Technology, the National Health Commission, the Chinese Academy of Sciences and Shanghai Municipality, to promote the integration
of production, academia, research and medicine 。 In this context, the "first domestic proton therapy demonstration device" jointly developed by the Shanghai Institute of Applied Physics/Shanghai Advanced Research Institute of the Chinese Academy of Sciences, relevant enterprises in Shanghai and Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine was officially approved in February 2012, led by Zhao Zhentang, director of Shanghai Light Source Science Center, and Ning Guang, president of Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
.
of production, academia, research and medicine 。 In this context, the "first domestic proton therapy demonstration device" jointly developed by the Shanghai Institute of Applied Physics/Shanghai Advanced Research Institute of the Chinese Academy of Sciences, relevant enterprises in Shanghai and Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine was officially approved in February 2012, led by Zhao Zhentang, director of Shanghai Light Source Science Center, and Ning Guang, president of Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
.
After verification, the overall function and performance of the domestic proton therapy system is comparable to that of imported similar devices, the operation is stable and reliable, and the domestic substitution is expected to further reduce the cost of equipment and medical costs, and provide cost-effective advanced treatment technology and equipment
for tumor patients.
At present, relevant enterprises have invested 620 million yuan in Jiading District, Shanghai to build a particle beam technology research and development and equipment manufacturing base integrating production, learning, research and use, and will carry out the research and development and industrialization transformation
of miniaturized proton therapy devices and multi-particle therapy devices according to the development needs of domestic particle radiotherapy and international development trends.
(End)
for tumor patients.
At present, relevant enterprises have invested 620 million yuan in Jiading District, Shanghai to build a particle beam technology research and development and equipment manufacturing base integrating production, learning, research and use, and will carry out the research and development and industrialization transformation
of miniaturized proton therapy devices and multi-particle therapy devices according to the development needs of domestic particle radiotherapy and international development trends.
(End)
The reporter learned on the 27th that the State Drug Administration approved the application for
registration of innovative products of "proton therapy system" produced by Shanghai enterprises.
In the future, the domestic proton therapy system will be officially put into use
in the Cancer Proton Center of Ruijin Hospital (hereinafter referred to as Ruijin Hospital) affiliated to Shanghai Jiao Tong University School of Medicine.
registration of innovative products of "proton therapy system" produced by Shanghai enterprises.
In the future, the domestic proton therapy system will be officially put into use
in the Cancer Proton Center of Ruijin Hospital (hereinafter referred to as Ruijin Hospital) affiliated to Shanghai Jiao Tong University School of Medicine.
The approved proton therapy system is used to treat solid malignancies and certain benign diseases
throughout the body.
Ruijin Hospital undertakes clinical trials as a clinical trial and carries out clinical trials of fixed beams and 180-degree rotating beam treatment rooms of proton therapy systems from the end of 2021
.
During the six-month clinical trial, the team of Ruijin Hospital verified the accuracy and stability of the proton ray range, determined the clinical application scenarios of the equipment according to the condition characteristics of different subjects, explored and established the proton therapy technology and clinical standardized operation specifications in line with the Chinese group, and formed a systematic, standardized and standardized program
for the application of the proton therapy system to tumor treatment.
Disease Disease Hospital Hospital Standard Standard Tumor Tumorsthroughout the body.
Ruijin Hospital undertakes clinical trials as a clinical trial and carries out clinical trials of fixed beams and 180-degree rotating beam treatment rooms of proton therapy systems from the end of 2021
.
During the six-month clinical trial, the team of Ruijin Hospital verified the accuracy and stability of the proton ray range, determined the clinical application scenarios of the equipment according to the condition characteristics of different subjects, explored and established the proton therapy technology and clinical standardized operation specifications in line with the Chinese group, and formed a systematic, standardized and standardized program
for the application of the proton therapy system to tumor treatment.
The clinical trial results proved that after the subjects were treated by proton beam irradiation, the tumor symptoms, signs and landmark tumor indicators were significantly improved, and the tumor control rate reached 100%, of which nearly half of the subjects' tumor lesions completely disappeared, and 10% of the subjects' tumor foci were significantly reduced; At the same time, the precise "blasting" of the proton beam effectively controls the dose and volume of irradiation on normal tissues, reduces the side effects of radiation therapy on normal tissues and the impact of treatment on the quality of life of
patients.
It is reported that in the next step, Ruijin Hospital will enter the stage
of formal clinical treatment of cancer patients.
patients.
It is reported that in the next step, Ruijin Hospital will enter the stage
of formal clinical treatment of cancer patients.
In February 2011, the Shanghai Municipal Government clearly regarded the "Development of the First Domestic Proton Therapy Device" and the "Ruijin Hospital Tumor Proton Center" project as a strategic and high-tech cooperation project between the Ministry of Science and Technology, the National Health Commission, the Chinese Academy of Sciences and Shanghai Municipality, to promote the integration
of production, academia, research and medicine 。 In this context, the "first domestic proton therapy demonstration device" jointly developed by the Shanghai Institute of Applied Physics/Shanghai Advanced Research Institute of the Chinese Academy of Sciences, relevant enterprises in Shanghai and Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine was officially approved in February 2012, led by Zhao Zhentang, director of Shanghai Light Source Science Center, and Ning Guang, president of Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
.
of production, academia, research and medicine 。 In this context, the "first domestic proton therapy demonstration device" jointly developed by the Shanghai Institute of Applied Physics/Shanghai Advanced Research Institute of the Chinese Academy of Sciences, relevant enterprises in Shanghai and Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine was officially approved in February 2012, led by Zhao Zhentang, director of Shanghai Light Source Science Center, and Ning Guang, president of Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
.
After verification, the overall function and performance of the domestic proton therapy system is comparable to that of imported similar devices, the operation is stable and reliable, and the domestic substitution is expected to further reduce the cost of equipment and medical costs, and provide cost-effective advanced treatment technology and equipment
for tumor patients.
At present, relevant enterprises have invested 620 million yuan in Jiading District, Shanghai to build a particle beam technology research and development and equipment manufacturing base integrating production, learning, research and use, and will carry out the research and development and industrialization transformation
of miniaturized proton therapy devices and multi-particle therapy devices according to the development needs of domestic particle radiotherapy and international development trends.
(End)
Enterprise enterprise for tumor patients.
At present, relevant enterprises have invested 620 million yuan in Jiading District, Shanghai to build a particle beam technology research and development and equipment manufacturing base integrating production, learning, research and use, and will carry out the research and development and industrialization transformation
of miniaturized proton therapy devices and multi-particle therapy devices according to the development needs of domestic particle radiotherapy and international development trends.
(End)
